SCHEMBL6428111

SCHEMBL6428111

Cc1ccccc1-c1c[nH]c(N)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.44
METAP2 P50579 1/20 0.44
PTPN1 P18031 1/20 0.40
ADORA2A P29274 1/20 0.40
ATP4A P20648 2/20 0.40
ATP4B P51164 2/20 0.40
DCUN1D1 Q96GG9 2/20 0.40
TLR8 Q9NR97 1/20 0.39
HSP90AA1 P07900 1/20 0.39
AR P10275 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
EPHA4 P54764 1/20 0.38
HEXA P06865 1/20 0.38
HEXB P07686 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12592216 0.81 CYP1A2 (0.43) ADORA2AARNPC1RAB9ASMN1; SMN2
SCHEMBL24090264 0.79 ALDH1A1 (0.43) ADORA2ATLR8ARRAB9ASMN1; SMN2
SCHEMBL8699164 0.78 IDO1 (0.44) IDO1METAP2PTPN1ATP4AATP4B
SCHEMBL30292494 0.78 HSP90AA1 (0.50) IDO1PTPN1ADORA2AATP4AATP4B
SCHEMBL24107433 0.78 HSP90AA1 (0.50) IDO1PTPN1ADORA2AATP4AATP4B
SCHEMBL4519295 0.78 XDH (0.42) ADORA2ADCUN1D1ALDH1A1
SCHEMBL1408091 0.77 HSP90AA1 (0.53) METAP2PTPN1ADORA2AATP4AATP4B
SCHEMBL9359350 0.76 IDO1 (0.43) IDO1METAP2PTPN1ATP4AATP4B
Lithium Ion SCHEMBL9356247 0.76 IDO1 (0.43) IDO1METAP2PTPN1ATP4AATP4B
SCHEMBL4491315 0.76 NOS1 (0.46) TLR8ALDH1A1HPGDDHFRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1175155-A4 METHOD FOR REDUCING A SUSCEPTIBILITY TO TUMOR FORMATION INDUCED BY 3-DEOXYGLUCOSONE AND PRECURSORS THEREOF FOX CHASE CANCER CT (US) 2005-10-19 EP disclosed
EP-1175155-A1 METHOD FOR REDUCING A SUSCEPTIBILITY TO TUMOR FORMATION INDUCED BY 3-DEOXYGLUCOSONE AND PRECURSORS THEREOF FOX CHASE CANCER CENTER (US) 2002-01-30 EP disclosed
WO-2000062626-A1 METHOD FOR REDUCING A SUSCEPTIBILITY TO TUMOR FORMATION INDUCED BY 3-DEOXYGLUCOSONE AND PRECURSORS THEREOF FOX CHASE CANCER CENTER (US) 2000-10-26 WO disclosed